English

MIRAVANT MEDICAL TECHNOLOGIES

EDGAR

Quarterly report (10-Q) · filed 2005-11-14

44 filing records in this dataset, filed from 1996-05-14 to 2005-11-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2004-12-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Cash and cash equivalents: 3.86 million USD 2005-09-30 Source
Exact value

3863000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2004-01-01 – 2004-12-31

Exact inputs and evidence

Revenue: 0 USD · 2004-01-01 – 2004-03-31 Source
Revenue: 0 USD · 2004-04-01 – 2004-06-30 Source
Revenue: 0 USD · 2004-07-01 – 2004-09-30 Source
Revenue: 0 USD · 2004-01-01 – 2004-12-31 Source
Revenue: 0 USD · 2004-01-01 – 2004-09-30 Source

Net income

-15.3 million USD

2004-10-01 – 2005-09-30

Exact inputs and evidence

Net income: -15896000 USD · 2004-01-01 – 2004-12-31 Source
Net income: -12640000 USD · 2004-01-01 – 2004-09-30 Source
Net income: -3710000 USD · 2005-01-01 – 2005-03-31 Source
Net income: -4885000 USD · 2005-04-01 – 2005-06-30 Source
Net income: -3485000 USD · 2005-07-01 – 2005-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2005-11-14.

Financial data available through: 2004-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2004-12-31
Operating income: 11 of 11 periods available· newest 2004-12-31
Net income: 11 of 11 periods available· newest 2004-12-31
Operating cash flow: 8 of 11 periods available· newest 2001-12-31
Capital expenditure: 8 of 11 periods available· newest 2001-12-31
Total assets: 10 of 11 periods available· newest 2004-12-31
liabilities: No compatible figures in this window
Current assets: 10 of 11 periods available· newest 2004-12-31
Current liabilities: 10 of 11 periods available· newest 2004-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2004-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2003-01-01 – 2003-12-31
Current period

USD 0

2004-01-01 – 2004-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
0 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MIRAVANT MEDICAL TECHNOLOGIES · 2004-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-05-000019.txt#14840 Input fundies:Revenue: 0 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-05-000019.txt#14840
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 8.43 million

Prior period

−USD 7.47 million

2003-01-01 – 2003-12-31
Current period

−USD 15.9 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

-15896000 − -7465000 = -8431000 USD

-7465000 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
-15896000 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MIRAVANT MEDICAL TECHNOLOGIES · 2004-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Year-over-year change in Net income: -8431000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -15896000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-05-000019.txt#15526 Input fundies:NetIncome: -7465000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-05-000019.txt#15526
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2004 2004-01-01 – 2004-12-31

Revenue USD 0
Operating costs Derived USD 13.05 million
Operating income −USD 13.05 million
Tax, interest and other Derived USD 2.84 million
Net income −USD 15.9 million

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Operating loss: operating costs were 2,383% of revenue.
1996 Operating loss: operating costs were 615% of revenue.
1997 Operating loss: operating costs were 1,539% of revenue.
1998 Operating loss: operating costs were 411% of revenue.
1999 Operating loss: operating costs were 258% of revenue.
2000 Operating loss: operating costs were 571% of revenue.
2001 Operating loss: operating costs were 434% of revenue.
2002 Operating loss: operating costs were 3,157% of revenue.
2003 Not shown: operating income or net income is not reported.
2004 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1995-01-01 – 1995-12-31	521000	12416000 Derived	-11895000	-185000 Derived	-11710000	-7811000 Derived	Source 1995-01-01 – 1995-12-31: 521000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -11895000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -11710000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -7801000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 10000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	3598000	22113000 Derived	-18515000	-2373000 Derived	-16142000	-16961000 Derived	Source 1996-01-01 – 1996-12-31: 3598000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -18515000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -16142000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -15106000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 1855000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	2278000	35065000 Derived	-32787000	-2578000 Derived	-30209000	-27751000 Derived	Source 1997-01-01 – 1997-12-31: 2278000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -32787000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -30209000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -23809000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 3942000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	10179000	41788000 Derived	-31609000	-3545000 Derived	-28064000	-24433000 Derived	Source 1998-01-01 – 1998-12-31: 10179000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -31609000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -28064000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -21702000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 2731000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	14577000	37639000 Derived	-23062000	-806000 Derived	-22256000	-18911000 Derived	Source 1999-01-01 – 1999-12-31: 14577000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -23062000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -22256000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -18360000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 551000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	4593000	26217000 Derived	-21624000	4369000 Derived	-25993000	-13636000 Derived	Source 2000-01-01 – 2000-12-31: 4593000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -21624000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -25993000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -13373000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 263000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	4683000	20330000 Derived	-15647000	755000 Derived	-16402000	-15534000 Derived	Source 2001-01-01 – 2001-12-31: 4683000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -15647000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -16402000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -15247000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 287000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	499000	15754000 Derived	-15255000	705000 Derived	-15960000	Unavailable	Source 2002-01-01 – 2002-12-31: 499000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -15255000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -15960000 USD Inspect Net Income Open source
2003 2003-01-01 – 2003-12-31	0	12236000 Derived	-12236000	-4771000 Derived	-7465000	Unavailable	Source 2003-01-01 – 2003-12-31: 0 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -12236000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -7465000 USD Inspect Net Income Open source
2004 2004-01-01 – 2004-12-31	0	13053000 Derived	-13053000	2843000 Derived	-15896000	Unavailable	Source 2004-01-01 – 2004-12-31: 0 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -13053000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -15896000 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2004

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Revenue	521000	Revenue: 521000 Open source
19961996-12-31	Revenue	3598000	Revenue: 3598000 Open source
19971997-12-31	Revenue	2278000	Revenue: 2278000 Open source
19981998-12-31	Revenue	10179000	Revenue: 10179000 Open source
19991999-12-31	Revenue	14577000	Revenue: 14577000 Open source
20002000-12-31	Revenue	4593000	Revenue: 4593000 Open source
20012001-12-31	Revenue	4683000	Revenue: 4683000 Open source
20022002-12-31	Revenue	499000	Revenue: 499000 Open source
20032003-12-31	Revenue	0	Revenue: 0 Open source
20042004-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2003

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Year over year	300.8%	Revenue: 521000 Open source Revenue: 130000 Open source
19961996-12-31	Year over year	590.6%	Revenue: 3598000 Open source Revenue: 521000 Open source
19971997-12-31	Year over year	-36.7%	Revenue: 2278000 Open source Revenue: 3598000 Open source
19981998-12-31	Year over year	346.8%	Revenue: 10179000 Open source Revenue: 2278000 Open source
19991999-12-31	Year over year	43.2%	Revenue: 14577000 Open source Revenue: 10179000 Open source
20002000-12-31	Year over year	-68.5%	Revenue: 4593000 Open source Revenue: 14577000 Open source
20012001-12-31	Year over year	2%	Revenue: 4683000 Open source Revenue: 4593000 Open source
20022002-12-31	Year over year	-89.3%	Revenue: 499000 Open source Revenue: 4683000 Open source
20032003-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 499000 Open source
20042004-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -3,057.1% 2002

Net margin -3,198.4% 2002

Free cash flow margin -331.7% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Operating margin	-2,283.1%	Operating Income: -11895000 Open source Revenue: 521000 Open source
19961996-12-31	Operating margin	-514.6%	Operating Income: -18515000 Open source Revenue: 3598000 Open source
19971997-12-31	Operating margin	-1,439.3%	Operating Income: -32787000 Open source Revenue: 2278000 Open source
19981998-12-31	Operating margin	-310.5%	Operating Income: -31609000 Open source Revenue: 10179000 Open source
19991999-12-31	Operating margin	-158.2%	Operating Income: -23062000 Open source Revenue: 14577000 Open source
20002000-12-31	Operating margin	-470.8%	Operating Income: -21624000 Open source Revenue: 4593000 Open source
20012001-12-31	Operating margin	-334.1%	Operating Income: -15647000 Open source Revenue: 4683000 Open source
20022002-12-31	Operating margin	-3,057.1%	Operating Income: -15255000 Open source Revenue: 499000 Open source
20032003-12-31	Operating margin	Not reported	Operating Income: -12236000 Open source Revenue: 0 Open source
20042004-12-31	Operating margin	Not reported	Operating Income: -13053000 Open source Revenue: 0 Open source
19951995-12-31	Net margin	-2,247.6%	Net Income: -11710000 Open source Revenue: 521000 Open source
19961996-12-31	Net margin	-448.6%	Net Income: -16142000 Open source Revenue: 3598000 Open source
19971997-12-31	Net margin	-1,326.1%	Net Income: -30209000 Open source Revenue: 2278000 Open source
19981998-12-31	Net margin	-275.7%	Net Income: -28064000 Open source Revenue: 10179000 Open source
19991999-12-31	Net margin	-152.7%	Net Income: -22256000 Open source Revenue: 14577000 Open source
20002000-12-31	Net margin	-565.9%	Net Income: -25993000 Open source Revenue: 4593000 Open source
20012001-12-31	Net margin	-350.2%	Net Income: -16402000 Open source Revenue: 4683000 Open source
20022002-12-31	Net margin	-3,198.4%	Net Income: -15960000 Open source Revenue: 499000 Open source
20032003-12-31	Net margin	Not reported	Net Income: -7465000 Open source Revenue: 0 Open source
20042004-12-31	Net margin	Not reported	Net Income: -15896000 Open source Revenue: 0 Open source
19951995-12-31	Free cash flow margin	-1,499.2%	Revenue: 521000 Open source Operating Cash Flow: -7801000 Open source Capital Expenditure: 10000 Open source
19961996-12-31	Free cash flow margin	-471.4%	Revenue: 3598000 Open source Operating Cash Flow: -15106000 Open source Capital Expenditure: 1855000 Open source
19971997-12-31	Free cash flow margin	-1,218.2%	Revenue: 2278000 Open source Operating Cash Flow: -23809000 Open source Capital Expenditure: 3942000 Open source
19981998-12-31	Free cash flow margin	-240%	Revenue: 10179000 Open source Operating Cash Flow: -21702000 Open source Capital Expenditure: 2731000 Open source
19991999-12-31	Free cash flow margin	-129.7%	Revenue: 14577000 Open source Operating Cash Flow: -18360000 Open source Capital Expenditure: 551000 Open source
20002000-12-31	Free cash flow margin	-296.9%	Revenue: 4593000 Open source Operating Cash Flow: -13373000 Open source Capital Expenditure: 263000 Open source
20012001-12-31	Free cash flow margin	-331.7%	Revenue: 4683000 Open source Operating Cash Flow: -15247000 Open source Capital Expenditure: 287000 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 499000 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -15.2M 2001

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Operating cash flow	-7801000	Operating Cash Flow: -7801000 Open source
19961996-12-31	Operating cash flow	-15106000	Operating Cash Flow: -15106000 Open source
19971997-12-31	Operating cash flow	-23809000	Operating Cash Flow: -23809000 Open source
19981998-12-31	Operating cash flow	-21702000	Operating Cash Flow: -21702000 Open source
19991999-12-31	Operating cash flow	-18360000	Operating Cash Flow: -18360000 Open source
20002000-12-31	Operating cash flow	-13373000	Operating Cash Flow: -13373000 Open source
20012001-12-31	Operating cash flow	-15247000	Operating Cash Flow: -15247000 Open source
20022002-12-31	Operating cash flow	Not reported	No source recorded
20032003-12-31	Operating cash flow	Not reported	No source recorded
20042004-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -15.5M 2001

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Free cash flow	-7811000	Operating Cash Flow: -7801000 Open source Capital Expenditure: 10000 Open source
19961996-12-31	Free cash flow	-16961000	Operating Cash Flow: -15106000 Open source Capital Expenditure: 1855000 Open source
19971997-12-31	Free cash flow	-27751000	Operating Cash Flow: -23809000 Open source Capital Expenditure: 3942000 Open source
19981998-12-31	Free cash flow	-24433000	Operating Cash Flow: -21702000 Open source Capital Expenditure: 2731000 Open source
19991999-12-31	Free cash flow	-18911000	Operating Cash Flow: -18360000 Open source Capital Expenditure: 551000 Open source
20002000-12-31	Free cash flow	-13636000	Operating Cash Flow: -13373000 Open source Capital Expenditure: 263000 Open source
20012001-12-31	Free cash flow	-15534000	Operating Cash Flow: -15247000 Open source Capital Expenditure: 287000 Open source
20022002-12-31	Free cash flow	Unavailable	No source recorded
20032003-12-31	Free cash flow	Unavailable	No source recorded
20042004-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1995-12-31	Liabilities / assets	Not reported	Total Assets: 11259000 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 59886000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 93031000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 23810000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 35823000 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 28027000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 16165000 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 3390000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 2405000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 7509000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.45× 2004

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Current assets / current liabilities	3.22×	Current Assets: 9292000 Open source Current Liabilities: 2889000 Open source
19961996-12-31	Current assets / current liabilities	17.37×	Current Assets: 54667000 Open source Current Liabilities: 3148000 Open source
19971997-12-31	Current assets / current liabilities	16.14×	Current Assets: 86067000 Open source Current Liabilities: 5333000 Open source
19981998-12-31	Current assets / current liabilities	3.7×	Current Assets: 15258000 Open source Current Liabilities: 4124000 Open source
19991999-12-31	Current assets / current liabilities	6.28×	Current Assets: 29653000 Open source Current Liabilities: 4720000 Open source
20002000-12-31	Current assets / current liabilities	6.88×	Current Assets: 22734000 Open source Current Liabilities: 3303000 Open source
20012001-12-31	Current assets / current liabilities	3.56×	Current Assets: 11832000 Open source Current Liabilities: 3321000 Open source
20022002-12-31	Current assets / current liabilities	0.18×	Current Assets: 1274000 Open source Current Liabilities: 7227000 Open source
20032003-12-31	Current assets / current liabilities	0.67×	Current Assets: 1328000 Open source Current Liabilities: 1992000 Open source
20042004-12-31	Current assets / current liabilities	3.45×	Current Assets: 6413000 Open source Current Liabilities: 1858000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1995-01-01 – 1995-12-31	−USD 11.71 million Exact value Exact value: -11710000 USD 1995-01-01 – 1995-12-31: -11710000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRAVANT MEDICAL TECHNOLOGIES · 1995-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Net Income: -11710000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11710000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0001047469-98-013073.txt#3611 The citation records this snapshot. The page link may show a newer release later.	−USD 7.8 million Exact value Exact value: -7801000 USD 1995-01-01 – 1995-12-31: -7801000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRAVANT MEDICAL TECHNOLOGIES · 1995-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Operating Cash Flow: -7801000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7801000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0001047469-98-013073.txt#3622 The citation records this snapshot. The page link may show a newer release later.	USD 10,000 Exact value Exact value: 10000 USD 1995-01-01 – 1995-12-31: 10000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRAVANT MEDICAL TECHNOLOGIES · 1995-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Capital Expenditure: 10000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0001047469-98-013073.txt#3629 The citation records this snapshot. The page link may show a newer release later.	−USD 7.81 million Calculation and evidence -7801000 − 10000 USD Exact free cash flow: -7811000 USD 1995-01-01 – 1995-12-31: -7801000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 10000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRAVANT MEDICAL TECHNOLOGIES · 1995-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Free cash flow: -7811000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7801000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0001047469-98-013073.txt#3622 Input fundies:CapitalExpenditure: 10000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0001047469-98-013073.txt#3629 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 16.14 million Exact value Exact value: -16142000 USD 1996-01-01 – 1996-12-31: -16142000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRAVANT MEDICAL TECHNOLOGIES · 1996-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Net Income: -16142000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16142000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-99-000005.txt#2827 The citation records this snapshot. The page link may show a newer release later.	−USD 15.11 million Exact value Exact value: -15106000 USD 1996-01-01 – 1996-12-31: -15106000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRAVANT MEDICAL TECHNOLOGIES · 1996-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Operating Cash Flow: -15106000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15106000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-99-000005.txt#2841 The citation records this snapshot. The page link may show a newer release later.	USD 1.86 million Exact value Exact value: 1855000 USD 1996-01-01 – 1996-12-31: 1855000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRAVANT MEDICAL TECHNOLOGIES · 1996-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Capital Expenditure: 1855000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1855000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-99-000005.txt#2848 The citation records this snapshot. The page link may show a newer release later.	−USD 16.96 million Calculation and evidence -15106000 − 1855000 USD Exact free cash flow: -16961000 USD 1996-01-01 – 1996-12-31: -15106000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 1855000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRAVANT MEDICAL TECHNOLOGIES · 1996-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Free cash flow: -16961000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15106000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-99-000005.txt#2841 Input fundies:CapitalExpenditure: 1855000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-99-000005.txt#2848 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 30.21 million Exact value Exact value: -30209000 USD 1997-01-01 – 1997-12-31: -30209000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRAVANT MEDICAL TECHNOLOGIES · 1997-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Net Income: -30209000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30209000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-00-000001.txt#2940 The citation records this snapshot. The page link may show a newer release later.	−USD 23.81 million Exact value Exact value: -23809000 USD 1997-01-01 – 1997-12-31: -23809000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRAVANT MEDICAL TECHNOLOGIES · 1997-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Operating Cash Flow: -23809000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23809000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-00-000001.txt#2956 The citation records this snapshot. The page link may show a newer release later.	USD 3.94 million Exact value Exact value: 3942000 USD 1997-01-01 – 1997-12-31: 3942000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRAVANT MEDICAL TECHNOLOGIES · 1997-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Capital Expenditure: 3942000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3942000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-00-000001.txt#2964 The citation records this snapshot. The page link may show a newer release later.	−USD 27.75 million Calculation and evidence -23809000 − 3942000 USD Exact free cash flow: -27751000 USD 1997-01-01 – 1997-12-31: -23809000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 3942000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRAVANT MEDICAL TECHNOLOGIES · 1997-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Free cash flow: -27751000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23809000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-00-000001.txt#2956 Input fundies:CapitalExpenditure: 3942000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-00-000001.txt#2964 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 28.06 million Exact value Exact value: -28064000 USD 1998-01-01 – 1998-12-31: -28064000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRAVANT MEDICAL TECHNOLOGIES · 1998-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Net Income: -28064000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28064000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-01-000001.txt#3323 The citation records this snapshot. The page link may show a newer release later.	−USD 21.7 million Exact value Exact value: -21702000 USD 1998-01-01 – 1998-12-31: -21702000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRAVANT MEDICAL TECHNOLOGIES · 1998-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Operating Cash Flow: -21702000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21702000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-01-000001.txt#3341 The citation records this snapshot. The page link may show a newer release later.	USD 2.73 million Exact value Exact value: 2731000 USD 1998-01-01 – 1998-12-31: 2731000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRAVANT MEDICAL TECHNOLOGIES · 1998-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Capital Expenditure: 2731000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2731000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-01-000001.txt#3349 The citation records this snapshot. The page link may show a newer release later.	−USD 24.43 million Calculation and evidence -21702000 − 2731000 USD Exact free cash flow: -24433000 USD 1998-01-01 – 1998-12-31: -21702000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 2731000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRAVANT MEDICAL TECHNOLOGIES · 1998-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Free cash flow: -24433000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21702000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-01-000001.txt#3341 Input fundies:CapitalExpenditure: 2731000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-01-000001.txt#3349 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 22.26 million Exact value Exact value: -22256000 USD 1999-01-01 – 1999-12-31: -22256000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRAVANT MEDICAL TECHNOLOGIES · 1999-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Net Income: -22256000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22256000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3911 The citation records this snapshot. The page link may show a newer release later.	−USD 18.36 million Exact value Exact value: -18360000 USD 1999-01-01 – 1999-12-31: -18360000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRAVANT MEDICAL TECHNOLOGIES · 1999-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Operating Cash Flow: -18360000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18360000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3929 The citation records this snapshot. The page link may show a newer release later.	USD 551,000 Exact value Exact value: 551000 USD 1999-01-01 – 1999-12-31: 551000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRAVANT MEDICAL TECHNOLOGIES · 1999-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Capital Expenditure: 551000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 551000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3935 The citation records this snapshot. The page link may show a newer release later.	−USD 18.91 million Calculation and evidence -18360000 − 551000 USD Exact free cash flow: -18911000 USD 1999-01-01 – 1999-12-31: -18360000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 551000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRAVANT MEDICAL TECHNOLOGIES · 1999-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Free cash flow: -18911000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18360000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3929 Input fundies:CapitalExpenditure: 551000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3935 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 25.99 million Exact value Exact value: -25993000 USD 2000-01-01 – 2000-12-31: -25993000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRAVANT MEDICAL TECHNOLOGIES · 2000-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Net Income: -25993000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25993000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-03-000002.txt#4325 The citation records this snapshot. The page link may show a newer release later.	−USD 13.37 million Exact value Exact value: -13373000 USD 2000-01-01 – 2000-12-31: -13373000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRAVANT MEDICAL TECHNOLOGIES · 2000-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Operating Cash Flow: -13373000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13373000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3929 The citation records this snapshot. The page link may show a newer release later.	USD 263,000 Exact value Exact value: 263000 USD 2000-01-01 – 2000-12-31: 263000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRAVANT MEDICAL TECHNOLOGIES · 2000-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Capital Expenditure: 263000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 263000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3935 The citation records this snapshot. The page link may show a newer release later.	−USD 13.64 million Calculation and evidence -13373000 − 263000 USD Exact free cash flow: -13636000 USD 2000-01-01 – 2000-12-31: -13373000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 263000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRAVANT MEDICAL TECHNOLOGIES · 2000-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Free cash flow: -13636000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13373000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3929 Input fundies:CapitalExpenditure: 263000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3935 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 16.4 million Exact value Exact value: -16402000 USD 2001-01-01 – 2001-12-31: -16402000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRAVANT MEDICAL TECHNOLOGIES · 2001-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Net Income: -16402000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16402000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-04-000010.txt#4191 The citation records this snapshot. The page link may show a newer release later.	−USD 15.25 million Exact value Exact value: -15247000 USD 2001-01-01 – 2001-12-31: -15247000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MIRAVANT MEDICAL TECHNOLOGIES · 2001-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Operating Cash Flow: -15247000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15247000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3929 The citation records this snapshot. The page link may show a newer release later.	USD 287,000 Exact value Exact value: 287000 USD 2001-01-01 – 2001-12-31: 287000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MIRAVANT MEDICAL TECHNOLOGIES · 2001-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Capital Expenditure: 287000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 287000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3935 The citation records this snapshot. The page link may show a newer release later.	−USD 15.53 million Calculation and evidence -15247000 − 287000 USD Exact free cash flow: -15534000 USD 2001-01-01 – 2001-12-31: -15247000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 287000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MIRAVANT MEDICAL TECHNOLOGIES · 2001-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Free cash flow: -15534000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15247000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3929 Input fundies:CapitalExpenditure: 287000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-02-000005.txt#3935 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 15.96 million Exact value Exact value: -15960000 USD 2002-01-01 – 2002-12-31: -15960000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRAVANT MEDICAL TECHNOLOGIES · 2002-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Net Income: -15960000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15960000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-05-000019.txt#15526 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 7.47 million Exact value Exact value: -7465000 USD 2003-01-01 – 2003-12-31: -7465000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRAVANT MEDICAL TECHNOLOGIES · 2003-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Net Income: -7465000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7465000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-05-000019.txt#15526 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 15.9 million Exact value Exact value: -15896000 USD 2004-01-01 – 2004-12-31: -15896000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MIRAVANT MEDICAL TECHNOLOGIES · 2004-12-31 MIRAVANT MEDICAL TECHNOLOGIES (edgar:933745) Net Income: -15896000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T15:07:54Z Snapshot: 5a74c6dce1f4641cf5d3c30c97a6539723e005473e1a5816a27f84d63b5cc930 Dimensions: Consolidated View: https://fundies.io/companies/edgar/933745/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15896000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/933745/0000933745-05-000019.txt#15526 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

44 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000933745, 933745, edgar:933745

Also known as PDT INC /DE/

MIRAVANT MEDICAL TECHNOLOGIES

Latest quarter

Revenue

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2004 2004-01-01 – 2004-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation